Corporate ActionJul 7, 2026, 04:17 PM
Wave Life Sciences Redomiciliation Proceeds to Singapore Court
AI Summary
Wave Life Sciences Ltd. announced that it has obtained the necessary shareholder approval for its proposed redomiciliation to the United States. The company has filed an application with the High Court of the Republic of Singapore to approve the scheme of arrangement, with a hearing scheduled for July 14, 2026. The redomiciliation remains subject to this court approval.
Key Highlights
- Shareholder approval obtained for proposed redomiciliation to the United States.
- Application filed with the High Court of Singapore on July 1, 2026, for scheme of arrangement approval.
- Singapore Court hearing scheduled for July 14, 2026, at 2:30 pm (Singapore Time).
- Affidavits in response to the application due by July 8, 2026, 4:00 pm (Singapore Time).
- Written submissions and bundles of authorities due by July 10, 2026, 4:00 pm (Singapore Time).
Price Impact
More from WVE